This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Under $10 Set to Trigger Big Moves

Human Genome Sciences

One name in the biotechnology and drugs sector that looks ready for a big breakout is Human Genome Sciences (HGSI) whose products include Benlysta (belimumab) for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The bears have hammered this stock during the past six months, with shares off by over 65%.

If you take a look at the chart for Human Genome Sciences, you'll notice that this stock plunged massively from its October high of $15.07 to its recent low of $6.51 a share. After printing that low, the stock has started to rebound and make higher lows, which is bullish price action. Now the stock is nearing a big breakout if it can manage to clear some near-term overhead resistance levels.

Traders should watch HGSI for a breakout trade if the stock can manage to sustain a high-volume move and close above $7.65 and $7.85 a share. Look for volume that's near or above its three-month average action of 6,166,384 shares. At last check, volume has registered over 6 million shares and HGSI has hit a daily high of $8.41 a share. I would consider it bullish if HGSI can close today at least above $7.85, or even better closer to its daily high.

One could be a buyer of HGSI off any strength where the stock closes above $7.85 and its 50-day moving average of $8.07 a share. If we get that action, then look for HGSI to take out $8.41 with decent volume. Some potential targets on the upside are $10 to $11 a share or much higher if the volume really starts to kick in.

This stock also has a decent short interest since 10.6% of the tradable float is currently sold short by the bears. Any lose back above the 50-day and above $8.41 should set off a decent short-squeeze, so keep this name on your trading radar.
5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
OCZ $0.00 0.00%
JVA $3.30 0.00%
SIRI $3.38 0.00%
AAPL $93.70 0.00%
FB $101.91 0.00%


Chart of I:DJI
DOW 15,660.18 -254.56 -1.60%
S&P 500 1,829.08 -22.78 -1.23%
NASDAQ 4,266.8370 -16.7550 -0.39%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs